Key takeaways

• As healthcare costs continue to climb, both public and private payors are pursuing strategies to expand access and contain costs.
• The FDA and state governments have recently announced initiatives that are aimed at directly or indirectly reducing prescription drug costs.
• Healthcare companies are using vertical integration as a means of controlling costs and developing new means of providing reasonably-priced, accessible healthcare.
• These initiatives provide strategic opportunities for healthcare companies that can enhance the efficacy and cost-effectiveness of healthcare goods and services.